ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...
Minoxidil (5% & 2%) Strategic Research Report 2025: Global Market to Grow by $300 Million to 2030 - Expanding E-Commerce Channels Propel Expansion
Understand the significant growth trajectory of the Minoxidil 5% segment, which is expected to reach US$1.6 Billion by 2030 ...